The Phosphatase Inhibitor Calyculin-A Impairs Clot Retraction, Platelet Activation, and Thrombin Generation
Joint Authors
Csernoch, László
Kappelmayer, János
Hudák, Renáta
Vincze, János
Beke Debreceni, Ildikó
Oláh, Tamás
Erdődi, Ferenc
Clemetson, Kenneth J.
Source
Issue
Vol. 2017, Issue 2017 (31 Dec. 2017), pp.1-10, 10 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2017-06-07
Country of Publication
Egypt
No. of Pages
10
Main Subjects
Abstract EN
The aim of this study was to investigate the effect of the serine/threonine protein phosphatase inhibitor, calyculin-A (CLA), on clot formation and on the procoagulant activity of human platelets.
Platelet-rich plasma (PRP) samples were preincubated with buffer or CLA and subsequently platelets were activated by the protease-activated receptor 1 (PAR-1) activator, thrombin receptor activating peptide (TRAP).
Clot retraction was detected by observing clot morphology up to 1 hour, phosphatidylserine- (PS-) expression was studied by flow cytometry, and thrombin generation was measured by a fluorimetric assay.
For the intracellular Ca2+ assay, platelets were loaded with calcium-indicator dyes and the measurements were carried out using a ratiometric method with real-time confocal microscopy.
CLA preincubation inhibited clot retraction, PS-expression, and thrombin formation.
TRAP activation elicited Ca2+ response and PS-expression in a subset of platelets.
The activated PRP displayed significantly faster and enhanced thrombin generation compared to nonactivated samples.
CLA pretreatment abrogated PS-exposure and clot retraction also in TRAP-activated samples.
As a consequence of the inhibitory effect on calcium elevation and PS-expression, CLA significantly downregulated thrombin generation in PRP.
Our results show that CLA pretreatment may be a useful tool to investigate platelet activation mechanisms that contribute to clot formation and thrombin generation.
American Psychological Association (APA)
Hudák, Renáta& Vincze, János& Csernoch, László& Beke Debreceni, Ildikó& Oláh, Tamás& Erdődi, Ferenc…[et al.]. 2017. The Phosphatase Inhibitor Calyculin-A Impairs Clot Retraction, Platelet Activation, and Thrombin Generation. BioMed Research International،Vol. 2017, no. 2017, pp.1-10.
https://search.emarefa.net/detail/BIM-1139728
Modern Language Association (MLA)
Hudák, Renáta…[et al.]. The Phosphatase Inhibitor Calyculin-A Impairs Clot Retraction, Platelet Activation, and Thrombin Generation. BioMed Research International No. 2017 (2017), pp.1-10.
https://search.emarefa.net/detail/BIM-1139728
American Medical Association (AMA)
Hudák, Renáta& Vincze, János& Csernoch, László& Beke Debreceni, Ildikó& Oláh, Tamás& Erdődi, Ferenc…[et al.]. The Phosphatase Inhibitor Calyculin-A Impairs Clot Retraction, Platelet Activation, and Thrombin Generation. BioMed Research International. 2017. Vol. 2017, no. 2017, pp.1-10.
https://search.emarefa.net/detail/BIM-1139728
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1139728